Can lithium be used with lisinopril, and how should it be monitored?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Lithium Be Used With Lisinopril?

Lithium can be used with lisinopril if clinically necessary, but this combination requires intensive monitoring due to significant risk of lithium toxicity. The combination should be avoided when safer alternatives exist, particularly in elderly patients or those with renal impairment 1, 2.

Key Safety Concerns

The primary risk stems from ACE inhibitors like lisinopril reducing renal lithium clearance through sodium loss, which can elevate serum lithium levels and precipitate toxicity 1, 2. The FDA drug label for lithium explicitly warns that "caution should be used when lithium and diuretics or angiotensin converting enzyme (ACE) inhibitors are used concomitantly because sodium loss may reduce the renal clearance of lithium and increase serum lithium levels with risk of lithium toxicity" 1.

Research demonstrates that ACE inhibitors can increase steady-state lithium concentrations by approximately 36% and reduce lithium clearance by 25.5%, with four out of 20 patients in one study developing symptoms of lithium toxicity 3. Another case report documented a five-fold increase in serum lithium levels (reaching 3.4 mEq/L) after switching from fosinopril to lisinopril 4.

When Combination Is Necessary

If the combination cannot be avoided:

  • Reduce the lithium dose preemptively when initiating lisinopril 1
  • Monitor serum lithium levels weekly for the first 4-6 weeks, then every 1-2 weeks until stable 5, 4
  • Check renal function (creatinine, GFR) and electrolytes (sodium, potassium) concurrently with each lithium level 6, 1
  • Ensure adequate hydration (2500-3000 mL daily) and normal salt intake 1, 5

High-Risk Populations Requiring Extra Caution

The KDOQI guidelines specifically note that lithium is "nephrotoxic and may cause renal tubular dysfunction with prolonged use even at therapeutic levels" and recommend monitoring "GFR, electrolytes, and lithium levels 6 monthly or more frequently if the dose changes or the patient is acutely unwell" 6.

Elderly patients are at particularly high risk, as 35% of lithium clearance changes were associated with age and baseline renal function 3. The combination should be strongly reconsidered in patients over 65 years.

Critical Contraindications to the Combination

Absolutely avoid this combination if:

  • Patient is concurrently taking thiazide or loop diuretics (especially hydrochlorothiazide) 5, 7
  • Patient is taking NSAIDs, which independently increase lithium levels 6, 8
  • GFR < 30 mL/min/1.73 m² 6
  • Patient has history of dehydration, diarrhea, or excessive sweating 1
  • Patient is hemodynamically unstable 2

The guideline on aldosterone antagonists notes that "lithium toxicity has been reported in patients receiving lithium concomitantly to diuretics or angiotensin converting enzyme inhibitors" and states "associating lithium to eplerenone should be avoided" 9, which extends to all RAAS inhibitors including lisinopril.

Patient Education Requirements

Patients must discontinue lithium and contact their physician immediately if signs of toxicity develop: diarrhea, vomiting, tremor, mild ataxia, drowsiness, or muscular weakness 1. They should be warned against using over-the-counter NSAIDs 8 and instructed to maintain consistent fluid and salt intake 1.

Alternative Approaches

Consider alternative antihypertensives that don't significantly affect lithium levels, such as calcium channel blockers (though data is limited). If blood pressure control is inadequate with alternatives, the lisinopril-lithium combination may be justified with the intensive monitoring protocol outlined above 5, 7.

Related Questions

What are the major interactions between lithium and lisinopril (Angiotensin-Converting Enzyme inhibitor)?
What are the guidelines for taking lithium (mood stabilizer) and lisinopril (angiotensin-converting enzyme inhibitor) together, especially in older adults or those with impaired renal function?
Is it safe to start an ACE inhibitor, ARB, or ARNI in a patient on chronic lithium therapy?
Does the caution against combining lisinopril with lithium (lithium carbonate) apply to low-dose 5mg lithium orotate?
In a stable outpatient on lithium with a level of 1.3–1.5 mEq/L, how should I determine whether this is critical and requires same‑day provider contact versus next‑business‑day review, based on symptom assessment and whether the level is a true trough, and should I hold the dose, reduce it, or switch mood stabilizers given concurrent use of an angiotensin‑converting‑enzyme (ACE) inhibitor, mild dehydration, or herbal agents?
Does doxycycline cover methicillin‑susceptible and methicillin‑resistant Staphylococcus aureus?
Should digoxin be used in patients with ventricular tachycardia and low left ventricular ejection fraction?
In a patient with a traumatic hip injury, should I order a contrast‑enhanced MRI (gadolinium) or a standard non‑contrast MRI?
In a patient with a low‑titer antinuclear antibody (ANA) of 1:80 showing a nucleolar pattern, a negative systemic autoimmune panel, elevated C‑reactive protein (CRP) of 18 mg/L, normal erythrocyte sedimentation rate (ESR), intermittent fatigue, nausea, blurry vision, headache, and metabolic syndrome, what is the clinical significance and what further evaluation and management are recommended?
What is the recommended management for a patient with triglycerides of 405 mg/dL?
Can Septrin (co‑trimoxazole) double‑strength be given with linezolid, and what infections does this combination cover?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.